Produto adicionado correctamente ao carrinho.

2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-, hydrochloride (1:1), (4S,4aS,12aS)-
Ver 3D

Indagoo logo

2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-, hydrochloride (1:1), (4S,4aS,12aS)-

CAS: 13803-65-1

Ref. AN-AG0017VE

5mg
Descontinuado
25mg
Descontinuado
100mg
Descontinuado
500mg
Descontinuado

Produto descontinuado. Para obter informações sobre produtos semelhantes, preencha o nosso formulário de pedido de informações ou envie-nos uma mensagem de correio eletrónico para .


Informação sobre produto

Nome:
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-, hydrochloride (1:1), (4S,4aS,12aS)-
Sinónimos:
  • [u'Anhydrotetracycline hydrochloride', u'13803-65-1', u'UNII-OVG14H105R', u'OVG14H105R', u"Anhydrotetracycline hydrochloride, 'can be used as a secondary standard'", u'(4S,4aS,12aS)-4-(Dimethylamino)-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide Hydrochloride (Anhydrotetracycline Hydrochloride)', u'(4S,4aS,12aS)-4-(dimethylamino)-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-4a,5-dihydro-4H-tetracene-2-carboxamide;hydrochloride', u'Anhydrotetracycline HCl', u'AC1O4BX8', u'C22H22N2O7.HCl', u'CHEMBL1950578', u'1618AH', u'MFCD00151453', u'AKOS032954190', u'2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,12aalpha))-', u'4-(Dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-2-naphthacenecarboxamide monohydrochloride, (4S-(4alpha,4aalpha,12aalpha))-', u'ST50405343', u'Anhydrotetracycline hydrochloride, VETRANAL(TM), analytical standard', u'Anhydrotetracycline hydrochloride, certified reference material, TraceCERT(R)', u'Anhydrotetracycline hydrochloride, European Pharmacopoeia (EP) Reference Standard', u'Anhydrotetracycline hydrochloride, United States Pharmacopeia (USP) Reference Standard', u'(2Z,4S,4aS,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-10,11,12a-trihydroxy-6-methyl-4a,5-dihydro-4H-tetracene-1,3,12-trione hydrochloride', u'(4S,12aS,4aS)-4-(dimethylamino)-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-4 ,5,12a,4a-tetrahydronaphthacene-2-carboxamide, chloride', u'(4S,4aS,12aS)-4-(Dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-2-naphthacenecarboxamide Hydrochloride', u'(4S,4aS,12aS)-4-(Dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-2-naphthacenecarboxamide monohydrochloride', u'(4S,4aS,12aS)-4-(dimethylamino)-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide hydrochloride', u'C22H22N2O7.ClH', u'C22-H22-N2-O7.Cl-H', u'CID6364623', u'CS-O-10838', u'CID 6364621', u'Anhydrotetracycline hydrochloride, 97% - 100MG 100mg', u'2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-, monohydrochloride, (4S,4aS,12aS)-']
  • (1S,4aS,12aS)-3-[amino(hydroxy)methylidene]-4a,6,7-trihydroxy-N,N,11-trimethyl-2,4,5-trioxo-1,2,3,4,4a,5,12,12a-octahydrotetracen-1-aminium
  • (2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-11,12a-dihydroxy-6-methyl-4a,12a-dihydrotetracene-1,3,12(2H,4H,5H)-trione hydrochloride
  • (2Z,4S,4aS,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-10,11,12a-trihydroxy-6-methyl-4a,12a-dihydrotetracene-1,3,12(2H,4H,5H)-trione hydrochloride
  • 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-,
  • 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-, monohydrochloride
  • 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-, monohydrochloride, (4S,4aS,12aS)-
  • 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-, monohydrochloride, [4S-(4α,4aα,12aα)]-
  • 4-(Dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-2-naphthacenecarboxamide monohydrochloride, (4S-(4alpha,4aalpha,12aalpha))- Anhydrotetracycline hydrochloride
  • monohydrochloride, (4S-(4alpha,4aalpha,12aalpha))-
  • Ver mais sinónimos
Marca:
Indagoo
Armazenamento a longo prazo:
Notas:

Propriedades químicas

Peso molecular:
462.8802
Fórmula:
C22H23ClN2O7
Pureza:
98%
Cor/forma:
Solid
InChI:
InChI=1S/C22H22N2O7.ClH/c1-8-9-5-4-6-12(25)13(9)17(26)14-10(8)7-11-16(24(2)3)18(27)15(21(23)30)20(29)22(11,31)19(14)28;/h4-6,11,16,25-26,29,31H,7H2,1-3H3,(H2,23,30);1H/t11-,16-,22-;/m0./s1
Chave InChI:
SPFAOPCHYIJPHJ-WPJNXPDPSA-N
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:

Informação sobre riscos

Número ONU:
EQ:
Classe:
Frases H:
Frases P:
Proibido de voar:
Informação sobre riscos:
Grupo de Embalagem:
LQ:

Consulta sobre o produto descontinuado: AN-AG0017VE 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-, hydrochloride (1:1), (4S,4aS,12aS)-

* Campos obrigatórios
Bem-vindo à CymitQuimica!Usamos cookies para melhorar sua visita. Não incluímos publicidade.

Consulte a nossa Política de Cookies para mais detalhes ou ajuste suas preferências em "Configurar".